2021 Q1 Form 10-Q Financial Statement

#000165495421005684 Filed on May 14, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $8.617M $7.772M
YoY Change 10.87% 0.96%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $260.0K $230.0K
YoY Change 13.04% -20.69%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $854.4K $1.476M
YoY Change -42.13% -4.04%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $3.702M $2.180M
YoY Change 69.84% 3.31%
Income Tax $676.5K $318.5K
% Of Pretax Income 18.27% 14.61%
Net Earnings $3.026M $1.861M
YoY Change 62.56% 5.04%
Net Earnings / Revenue 35.11% 23.95%
Basic Earnings Per Share $0.57 $0.35
Diluted Earnings Per Share $569.5K $354.3K
COMMON SHARES
Basic Shares Outstanding 5.322M shares 5.245M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $93.19M $38.63M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $12.56M $10.80M
YoY Change 16.28% -2.7%
Goodwill $11.57M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $937.5M $751.7M
YoY Change 24.72% 6.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.700M $3.200M
YoY Change -15.63% -34.69%
Accrued Expenses $1.000M $1.200M
YoY Change -16.67%
Deferred Revenue
YoY Change
Short-Term Debt $32.10M $22.90M
YoY Change 40.17% -30.18%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.700M $4.400M
YoY Change -15.91% -10.2%
LONG-TERM LIABILITIES
Long-Term Debt $15.30M $13.00M
YoY Change 17.69% 0.78%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $15.30M $13.00M
YoY Change 17.69% 0.78%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.700M $4.400M
Total Long-Term Liabilities $15.30M $13.00M
Total Liabilities $859.4M $681.1M
YoY Change 26.18% 5.91%
SHAREHOLDERS EQUITY
Retained Earnings $31.21M
YoY Change
Common Stock $13.86M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $2.623M
YoY Change
Treasury Stock Shares 210.1K shares
Shareholders Equity $78.09M $70.58M
YoY Change
Total Liabilities & Shareholders Equity $937.5M $751.7M
YoY Change 24.72% 6.37%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income $3.026M $1.861M
YoY Change 62.56% 5.04%
Depreciation, Depletion And Amortization $260.0K $230.0K
YoY Change 13.04% -20.69%
Cash From Operating Activities $5.877M $907.7K
YoY Change 547.48% -55.51%
INVESTING ACTIVITIES
Capital Expenditures -$2.660M -$120.0K
YoY Change 2116.67% -55.56%
Acquisitions
YoY Change
Other Investing Activities -$43.28M -$22.79M
YoY Change 89.91% 2273.96%
Cash From Investing Activities -$45.94M -$22.92M
YoY Change 100.44% 1763.24%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $500.0K $0.00
YoY Change
Cash From Financing Activities $18.20M $12.08M
YoY Change 50.72% -171.81%
NET CHANGE
Cash From Operating Activities $5.877M $907.7K
Cash From Investing Activities -$45.94M -$22.92M
Cash From Financing Activities $18.20M $12.08M
Net Change In Cash -$21.86M -$9.932M
YoY Change 120.06% -37.97%
FREE CASH FLOW
Cash From Operating Activities $5.877M $907.7K
Capital Expenditures -$2.660M -$120.0K
Free Cash Flow $8.537M $1.028M
YoY Change 730.71% -55.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5332963 shares
CY2021Q1 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
719749186 USD
CY2020Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
700951104 USD
CY2021Q1 cmtv Time Deposits Over
TimeDepositsOver
250000 USD
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
15 shares
CY2021Q1 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
100000 USD
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
2.50
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
15000000 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5527380 shares
CY2021Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
8253296 USD
CY2020Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
7365961 USD
CY2021Q1 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
265112 USD
CY2020Q1 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
284756 USD
CY2021Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
267497 USD
CY2020Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
376503 USD
CY2021Q1 us-gaap Other Income
OtherIncome
415328 USD
CY2020Q1 us-gaap Other Income
OtherIncome
186566 USD
CY2021Q1 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
6159927 USD
CY2020Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
4239419 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1713796 USD
CY2021Q1 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
1975003 USD
CY2020Q1 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
1886316 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3702171 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2179744 USD
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5322404 shares
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.22
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
3025701 USD
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-1660640 USD
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
742589 USD
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
348735 USD
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-155943 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1311905 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
586646 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2447885 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
77288713 USD
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
264779 USD
CY2021Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
-1169555 USD
CY2021Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
-12188 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
3025701 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1311905 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
78085545 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
68894679 USD
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
254277 USD
CY2020Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
-995536 USD
CY2020Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
-17813 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
1861239 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
586646 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
70583492 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
3025701 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
1861239 USD
CY2021Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
259449 USD
CY2020Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
232759 USD
CY2021Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
267497 USD
CY2020Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
376503 USD
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
16608 USD
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-61497 USD
CY2021Q1 cmtv Loan And Lease Receivable Consumer
LoanAndLeaseReceivableConsumer
3666921 USD
CY2020Q4 cmtv Loan And Lease Receivable Consumer
LoanAndLeaseReceivableConsumer
4280990 USD
CY2021Q1 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
-114211 USD
CY2020Q1 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
-51183 USD
CY2021Q1 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
0 USD
CY2020Q1 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
-7799 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
1693014 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-91909 USD
CY2021Q1 cmtv Loans Receivable Real Estate Commercial
LoansReceivableRealEstateCommercial
278483091 USD
CY2020Q4 cmtv Loans Receivable Real Estate Commercial
LoansReceivableRealEstateCommercial
280544550 USD
CY2021Q1 cmtv Loans Receivable Municipal
LoansReceivableMunicipal
52207213 USD
CY2020Q4 cmtv Loans Receivable Municipal
LoansReceivableMunicipal
54807367 USD
CY2021Q1 cmtv Residential Real Estate First St Lien
ResidentialRealEstateFirstStLien
169810218 USD
CY2020Q4 cmtv Residential Real Estate First St Lien
ResidentialRealEstateFirstStLien
170507263 USD
CY2021Q1 cmtv Residential Real Estate Jr Lien
ResidentialRealEstateJrLien
36878573 USD
CY2020Q4 cmtv Residential Real Estate Jr Lien
ResidentialRealEstateJrLien
38147659 USD
CY2021Q1 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
2272165 USD
CY2020Q4 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
1195741 USD
CY2021Q1 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
719749186 USD
CY2020Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
700951104 USD
CY2021Q1 cmtv Financing Receivable Recorded Investment30 To89 Days Past Due
FinancingReceivableRecordedInvestment30To89DaysPastDue
3171529 USD
CY2021Q1 cmtv Financing Receivable Recorded Investment90 Days Or More Past Due
FinancingReceivableRecordedInvestment90DaysOrMorePastDue
1525936 USD
CY2021Q1 cmtv Notes Receivable Gross Financial Asset Past Due
NotesReceivableGrossFinancialAssetPastDue
4697465 USD
CY2021Q1 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
3672227 USD
CY2021Q1 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
609618 USD
CY2020Q4 cmtv Financing Receivable Recorded Investment30 To89 Days Past Due
FinancingReceivableRecordedInvestment30To89DaysPastDue
2151905 USD
CY2021Q1 cmtv Residential Mortgage Loans In Process Of Foreclosure Number Of Loans
ResidentialMortgageLoansInProcessOfForeclosureNumberOfLoans
6 integer
CY2021Q1 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
310137 USD
CY2020Q4 cmtv Residential Mortgage Loans In Process Of Foreclosure Number Of Loans
ResidentialMortgageLoansInProcessOfForeclosureNumberOfLoans
6 integer
CY2020Q4 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
312807 USD
CY2021Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
95456 USD
CY2020Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
13315 USD
CY2021Q1 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
2145611 USD
CY2020Q1 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
3736533 USD
CY2021Q1 us-gaap Payments For Origination And Purchases Of Loans Held For Sale
PaymentsForOriginationAndPurchasesOfLoansHeldForSale
-2435200 USD
CY2020Q1 us-gaap Payments For Origination And Purchases Of Loans Held For Sale
PaymentsForOriginationAndPurchasesOfLoansHeldForSale
-4352350 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
569100 USD
CY2020Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
295831 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-250630 USD
CY2020Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-553999 USD
CY2021Q1 us-gaap Servicing Asset At Amortized Value Period Increase Decrease
ServicingAssetAtAmortizedValuePeriodIncreaseDecrease
38280 USD
CY2020Q1 us-gaap Servicing Asset At Amortized Value Period Increase Decrease
ServicingAssetAtAmortizedValuePeriodIncreaseDecrease
24285 USD
CY2021Q1 cmtv Increase Decrease In Right Of Use Assets
IncreaseDecreaseInRightOfUseAssets
49031 USD
CY2020Q1 cmtv Increase Decrease In Right Of Use Assets
IncreaseDecreaseInRightOfUseAssets
60825 USD
CY2021Q1 us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
-49198 USD
CY2020Q1 us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
-60219 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-148665 USD
CY2020Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-143340 USD
CY2021Q1 us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
-21673 USD
CY2020Q1 us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
-21078 USD
CY2021Q1 cmtv Amortization Of Limited Partnership
AmortizationOfLimitedPartnership
90762 USD
CY2020Q1 cmtv Amortization Of Limited Partnership
AmortizationOfLimitedPartnership
84171 USD
CY2021Q1 us-gaap Increase Decrease In Loans Deferred Income
IncreaseDecreaseInLoansDeferredIncome
1076424 USD
CY2020Q1 us-gaap Increase Decrease In Loans Deferred Income
IncreaseDecreaseInLoansDeferredIncome
6777 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-12953 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-6398 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-420431 USD
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-411204 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
3175 USD
CY2020Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-23573 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5877147 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
907689 USD
CY2021Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
4383743 USD
CY2020Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
5817816 USD
CY2021Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
27371666 USD
CY2020Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
992000 USD
CY2021Q1 us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
0 USD
CY2020Q1 us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
361600 USD
CY2021Q1 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
0 USD
CY2020Q1 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
344700 USD
CY2021Q1 cmtv Decrease In Limited Partnership Contributions Payable
DecreaseInLimitedPartnershipContributionsPayable
150000 USD
CY2020Q1 cmtv Decrease In Limited Partnership Contributions Payable
DecreaseInLimitedPartnershipContributionsPayable
288000 USD
CY2021Q1 us-gaap Increase Decrease In Other Loans
IncreaseDecreaseInOtherLoans
20167317 USD
CY2020Q1 us-gaap Increase Decrease In Other Loans
IncreaseDecreaseInOtherLoans
27559512 USD
CY2021Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
-2657300 USD
CY2020Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
-123900 USD
CY2021Q1 us-gaap Proceeds From Sale Of Other Real Estate
ProceedsFromSaleOfOtherRealEstate
0 USD
CY2020Q1 us-gaap Proceeds From Sale Of Other Real Estate
ProceedsFromSaleOfOtherRealEstate
193299 USD
CY2021Q1 us-gaap Proceeds From Recoveries Of Loan Previously Charged Off
ProceedsFromRecoveriesOfLoanPreviouslyChargedOff
25314 USD
CY2020Q1 us-gaap Proceeds From Recoveries Of Loan Previously Charged Off
ProceedsFromRecoveriesOfLoanPreviouslyChargedOff
17530 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-45937226 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-22917867 USD
CY2021Q1 us-gaap Net Change Interest Bearing Deposits Domestic
NetChangeInterestBearingDepositsDomestic
7863790 USD
CY2020Q1 us-gaap Net Change Interest Bearing Deposits Domestic
NetChangeInterestBearingDepositsDomestic
-1133474 USD
CY2021Q1 us-gaap Increase Decrease In Savings Deposits
IncreaseDecreaseInSavingsDeposits
19474878 USD
CY2020Q1 us-gaap Increase Decrease In Savings Deposits
IncreaseDecreaseInSavingsDeposits
9922848 USD
CY2021Q1 us-gaap Increase Decrease In Time Deposits
IncreaseDecreaseInTimeDeposits
-3639187 USD
CY2020Q1 us-gaap Increase Decrease In Time Deposits
IncreaseDecreaseInTimeDeposits
-5666046 USD
CY2021Q1 us-gaap Proceeds From Payments For In Securities Sold Under Agreements To Repurchase
ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase
-6627854 USD
CY2020Q1 us-gaap Proceeds From Payments For In Securities Sold Under Agreements To Repurchase
ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase
-10279113 USD
CY2021Q1 cmtv Net Increase In Short Term Borrowings
NetIncreaseInShortTermBorrowings
0 USD
CY2020Q1 cmtv Net Increase In Short Term Borrowings
NetIncreaseInShortTermBorrowings
20000000 USD
CY2021Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
-500000 USD
CY2020Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
CY2021Q1 cmtv Increase Decrease In Finance Lease Obligations
IncreaseDecreaseInFinanceLeaseObligations
2388819 USD
CY2020Q1 cmtv Increase Decrease In Finance Lease Obligations
IncreaseDecreaseInFinanceLeaseObligations
-14987 USD
CY2021Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
-12188 USD
CY2020Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
-17813 USD
CY2021Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
-743679 USD
CY2020Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
-732972 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
18204579 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12078443 USD
CY2021Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-21855500 USD
CY2020Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-9931735 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
115049920 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
48562212 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
93194420 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38630477 USD
CY2021Q1 us-gaap Interest Paid
InterestPaid
867375 USD
CY2020Q1 us-gaap Interest Paid
InterestPaid
1482791 USD
CY2021Q1 cmtv Change In Unrealized Loss Gain On Securities Afs
ChangeInUnrealizedLossGainOnSecuritiesAfs
-1660640 USD
CY2020Q1 cmtv Change In Unrealized Loss Gain On Securities Afs
ChangeInUnrealizedLossGainOnSecuritiesAfs
742589 USD
CY2021Q1 us-gaap Dividends Common Stock
DividendsCommonStock
1169555 USD
CY2020Q1 us-gaap Dividends Common Stock
DividendsCommonStock
995536 USD
CY2021Q1 cmtv Increase In Dividends Payable Attributable To Dividends Declared
IncreaseInDividendsPayableAttributableToDividendsDeclared
-161097 USD
CY2020Q1 cmtv Increase In Dividends Payable Attributable To Dividends Declared
IncreaseInDividendsPayableAttributableToDividendsDeclared
-8287 USD
CY2021Q1 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
-264779 USD
CY2020Q1 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
-254277 USD
CY2021Q1 us-gaap Dividends Common Stock Stock
DividendsCommonStockStock
743679 USD
CY2020Q1 us-gaap Dividends Common Stock Stock
DividendsCommonStockStock
732972 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
3025701 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
1861239 USD
CY2021Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
12188 USD
CY2020Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
17813 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3013513 USD
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1843426 USD
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5322404 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5245216 shares
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.57
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.35
CY2021Q1 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
82438976 USD
CY2021Q1 us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
741401 USD
CY2021Q1 us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
1243372 USD
CY2021Q1 us-gaap Available For Sale Securities
AvailableForSaleSecurities
81937005 USD
CY2020Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
59546509 USD
CY2020 us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
1192865 USD
CY2020 us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
34196 USD
CY2020Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
60705178 USD
CY2021Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
55619893 USD
CY2021Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
1237388 USD
CY2021Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
302533 USD
CY2021Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
5984 USD
CY2021Q1 us-gaap Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1
45 integer
CY2021Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
55922426 USD
CY2021Q1 us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
1243372 USD
CY2020Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
4075401 USD
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
23090 USD
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
520546 USD
CY2020Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
11106 USD
CY2020Q4 us-gaap Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1
8 integer
CY2020Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
4595947 USD
CY2020 us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
34196 USD
CY2021Q1 cmtv Loans Receivable Commercial Industrial
LoansReceivableCommercialIndustrial
188443623 USD
CY2020Q4 cmtv Loans Receivable Commercial Industrial
LoansReceivableCommercialIndustrial
161067501 USD
CY2021Q1 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
729489639 USD
CY2020Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
709355330 USD
CY2021Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
7468288 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
7208485 USD
CY2021Q1 us-gaap Financing Receivable Covered Before Allowance For Credit Loss
FinancingReceivableCoveredBeforeAllowanceForCreditLoss
724792174 USD
CY2021Q1 cmtv Loans Gross
LoansGross
729489639 USD
CY2020Q4 cmtv Financing Receivable Recorded Investment90 Days Or More Past Due
FinancingReceivableRecordedInvestment90DaysOrMorePastDue
1577012 USD
CY2020Q4 cmtv Notes Receivable Gross Financial Asset Past Due
NotesReceivableGrossFinancialAssetPastDue
3728917 USD
CY2020Q4 us-gaap Financing Receivable Covered Before Allowance For Credit Loss
FinancingReceivableCoveredBeforeAllowanceForCreditLoss
705626413 USD
CY2020Q4 cmtv Loans Gross
LoansGross
709355330 USD
CY2020Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
4674764 USD
CY2020Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
489177 USD
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
6066932 USD
CY2020Q4 us-gaap Allowance For Loan And Lease Losses Real Estate
AllowanceForLoanAndLeaseLossesRealEstate
7208485 USD
CY2021Q1 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
-33008 USD
CY2021Q1 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
25314 USD
CY2021Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
267497 USD
CY2021Q1 us-gaap Allowance For Loan And Lease Losses Real Estate
AllowanceForLoanAndLeaseLossesRealEstate
7468288 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
119561 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
7348727 USD
CY2021Q1 cmtv Total All Evaluted For Impairment
TotalAllEvalutedForImpairment
7468288 USD
CY2021Q1 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
6604259 USD
CY2021Q1 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
722885380 USD
CY2021Q1 cmtv Total Loans Evaluted For Impairment
TotalLoansEvalutedForImpairment
729489639 USD
CY2019Q4 us-gaap Allowance For Loan And Lease Losses Real Estate
AllowanceForLoanAndLeaseLossesRealEstate
5926491 USD
CY2020 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
-379971 USD
CY2020 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
72965 USD
CY2020 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
1589000 USD
CY2020Q4 us-gaap Allowance For Loan And Lease Losses Real Estate
AllowanceForLoanAndLeaseLossesRealEstate
7208485 USD
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
108781 USD
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
7099704 USD
CY2020 cmtv Total All Evaluted For Impairment
TotalAllEvalutedForImpairment
7208485 USD
CY2020Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
7150092 USD
CY2020Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
702205238 USD
CY2020 cmtv Total Loans Evaluted For Impairment
TotalLoansEvalutedForImpairment
709355330 USD
CY2019Q4 us-gaap Allowance For Loan And Lease Losses Real Estate
AllowanceForLoanAndLeaseLossesRealEstate
5926491 USD
CY2020Q1 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
-133760 USD
CY2020Q1 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
17530 USD
CY2020Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
376503 USD
CY2020Q1 us-gaap Allowance For Loan And Lease Losses Real Estate
AllowanceForLoanAndLeaseLossesRealEstate
6186764 USD
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
119832 USD
CY2020Q1 cmtv Total All Evaluted For Impairment
TotalAllEvalutedForImpairment
6186764 USD
CY2020Q1 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
7138699 USD
CY2020Q1 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
627275991 USD
CY2020Q1 cmtv Total Loans Evaluted For Impairment
TotalLoansEvalutedForImpairment
634414690 USD
CY2021Q1 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
6639023 USD
CY2021Q1 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
8103430 USD
CY2021Q1 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
119561 USD
CY2021Q1 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
6910952 USD
CY2021Q1 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
67973 USD
CY2021Q1 cmtv Accrued Interest Receivable And Deferred Net Loan Costs
AccruedInterestReceivableAndDeferredNetLoanCosts
34764 USD
CY2020Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
7182881 USD
CY2020Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
8598095 USD
CY2020Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
108781 USD
CY2020 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
7080823 USD
CY2020 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
329151 USD
CY2020Q4 cmtv Accrued Interest Receivable And Deferred Net Loan Costs
AccruedInterestReceivableAndDeferredNetLoanCosts
32789 USD
CY2020Q1 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
7160670 USD
CY2020Q1 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
8385468 USD
CY2020Q1 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
119832 USD
CY2020Q1 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
6965434 USD
CY2020Q1 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
75729 USD
CY2020Q1 cmtv Accrued Interest Receivable And Deferred Net Loan Costs
AccruedInterestReceivableAndDeferredNetLoanCosts
21971 USD
CY2021Q1 cmtv Group A Acceptable Risk Loan
GroupAAcceptableRiskLoan
707491317 USD
CY2021Q1 cmtv Group B Management Involved Loans
GroupBManagementInvolvedLoans
10704378 USD
CY2021Q1 cmtv Loans Gross Amount
LoansGrossAmount
729489639 USD
CY2020Q4 cmtv Group A Acceptable Risk Loan
GroupAAcceptableRiskLoan
683098754 USD
CY2020Q4 cmtv Group B Management Involved Loans
GroupBManagementInvolvedLoans
13782719 USD
CY2020Q4 cmtv Group C Unacceptable Risk Loan
GroupCUnacceptableRiskLoan
12473857 USD
CY2020Q4 cmtv Loans Gross Amount
LoansGrossAmount
709355330 USD
CY2021Q1 us-gaap Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
2 integer
CY2021Q1 us-gaap Financing Receivable Modifications Subsequent Default Recorded Investment1
FinancingReceivableModificationsSubsequentDefaultRecordedInvestment1
203822 USD
CY2021Q1 cmtv Allowance Related To Tdrs
AllowanceRelatedToTdrs
119561 USD
CY2020Q4 cmtv Allowance Related To Tdrs
AllowanceRelatedToTdrs
108781 USD
CY2020Q4 us-gaap Servicing Asset At Amortized Value
ServicingAssetAtAmortizedValue
922146 USD
CY2019Q4 us-gaap Servicing Asset At Amortized Value
ServicingAssetAtAmortizedValue
939577 USD
CY2021Q1 us-gaap Payments For Proceeds From Mortgage Servicing Rights
PaymentsForProceedsFromMortgageServicingRights
16210 USD
CY2020 us-gaap Payments For Proceeds From Mortgage Servicing Rights
PaymentsForProceedsFromMortgageServicingRights
292654 USD
CY2021Q1 us-gaap Amortization Of Mortgage Servicing Rights Ms Rs
AmortizationOfMortgageServicingRightsMSRs
54490 USD
CY2020 us-gaap Amortization Of Mortgage Servicing Rights Ms Rs
AmortizationOfMortgageServicingRightsMSRs
256435 USD
CY2021Q1 us-gaap Valuation Allowances And Reserves Adjustments
ValuationAllowancesAndReservesAdjustments
0 USD
CY2020 us-gaap Valuation Allowances And Reserves Adjustments
ValuationAllowancesAndReservesAdjustments
-53650 USD
CY2021Q1 us-gaap Servicing Asset At Amortized Value
ServicingAssetAtAmortizedValue
883866 USD
CY2020Q4 us-gaap Servicing Asset At Amortized Value
ServicingAssetAtAmortizedValue
922146 USD
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.22

Files In Submission

Name View Source Status
0001654954-21-005684-index-headers.html Edgar Link pending
0001654954-21-005684-index.html Edgar Link pending
0001654954-21-005684.txt Edgar Link pending
0001654954-21-005684-xbrl.zip Edgar Link pending
cmtv-20210331.xsd Edgar Link pending
cmtv-20210331_cal.xml Edgar Link unprocessable
cmtv-20210331_def.xml Edgar Link unprocessable
cmtv-20210331_lab.xml Edgar Link unprocessable
cmtv-20210331_pre.xml Edgar Link unprocessable
cmtv_10q.htm Edgar Link pending
cmtv_10qimg1.jpg Edgar Link pending
cmtv_10q_htm.xml Edgar Link completed
cmtv_ex311.htm Edgar Link pending
cmtv_ex312.htm Edgar Link pending
cmtv_ex321.htm Edgar Link pending
cmtv_ex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending